CDKN2A and cutaneous melanoma: Aberrations of the p16INK4A:cyclin D-CK4/6:RB pathway is frequently observed in both cutaneous melanomas and acral melanomas with a prevalence of 68.8–82.7% [10,15,17,52,53].